TY - JOUR
T1 - Retrograde Lymph Flow Leads to Chylothorax in Transgenic Mice with Lymphatic Malformations
AU - Nitschké, Maximilian
AU - Bell, Alexander
AU - Karaman, Sinem
AU - Amouzgar, Meelad
AU - Rutkowski, Joseph M.
AU - Scherer, Philipp E.
AU - Alitalo, Kari
AU - McDonald, Donald M.
N1 - Funding Information:
Supported in part by National Heart, Lung, and Blood Institute, NIH, grants P01 HL024136, R01 HL059157, and R01 HL127402 (D.M.M.), the Leducq Foundation Transatlantic Network of Excellence grant 11CVD03, Lymph Vessels in Obesity and Cardiovascular Disease grant 11CVD03 (K.A. and D.M.M.), the Angel-Works Foundation (D.M.M.), and the Swiss National Science Foundation grants PBEZP3_145983 (M.N.) and P300PB_164732 (S.K.).
Publisher Copyright:
© 2017 American Society for Investigative Pathology
PY - 2017/9
Y1 - 2017/9
N2 - Chylous pleural effusion (chylothorax) frequently accompanies lymphatic vessel malformations and other conditions with lymphatic defects. Although retrograde flow of chyle from the thoracic duct is considered a potential mechanism underlying chylothorax in patients and mouse models, the path chyle takes to reach the thoracic cavity is unclear. Herein, we use a novel transgenic mouse model, where doxycycline-induced overexpression of vascular endothelial growth factor (VEGF)-C was driven by the adipocyte-specific promoter adiponectin (ADN), to determine how chylothorax forms. Surprisingly, 100% of adult ADN–VEGF-C mice developed chylothorax within 7 days. Rapid, consistent appearance of chylothorax enabled us to examine the step-by-step development in otherwise normal adult mice. Dynamic imaging with a fluorescent tracer revealed that lymph in the thoracic duct of these mice could enter the thoracic cavity by retrograde flow into enlarged paravertebral lymphatics and subpleural lymphatic plexuses that had incompetent lymphatic valves. Pleural mesothelium overlying the lymphatic plexuses underwent exfoliation that increased during doxycycline exposure. Together, the findings indicate that chylothorax in ADN–VEGF-C mice results from retrograde flow of chyle from the thoracic duct into lymphatic tributaries with defective valves. Chyle extravasates from these plexuses and enters the thoracic cavity through exfoliated regions of the pleural mesothelium.
AB - Chylous pleural effusion (chylothorax) frequently accompanies lymphatic vessel malformations and other conditions with lymphatic defects. Although retrograde flow of chyle from the thoracic duct is considered a potential mechanism underlying chylothorax in patients and mouse models, the path chyle takes to reach the thoracic cavity is unclear. Herein, we use a novel transgenic mouse model, where doxycycline-induced overexpression of vascular endothelial growth factor (VEGF)-C was driven by the adipocyte-specific promoter adiponectin (ADN), to determine how chylothorax forms. Surprisingly, 100% of adult ADN–VEGF-C mice developed chylothorax within 7 days. Rapid, consistent appearance of chylothorax enabled us to examine the step-by-step development in otherwise normal adult mice. Dynamic imaging with a fluorescent tracer revealed that lymph in the thoracic duct of these mice could enter the thoracic cavity by retrograde flow into enlarged paravertebral lymphatics and subpleural lymphatic plexuses that had incompetent lymphatic valves. Pleural mesothelium overlying the lymphatic plexuses underwent exfoliation that increased during doxycycline exposure. Together, the findings indicate that chylothorax in ADN–VEGF-C mice results from retrograde flow of chyle from the thoracic duct into lymphatic tributaries with defective valves. Chyle extravasates from these plexuses and enters the thoracic cavity through exfoliated regions of the pleural mesothelium.
UR - http://www.scopus.com/inward/record.url?scp=85027543573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027543573&partnerID=8YFLogxK
U2 - 10.1016/j.ajpath.2017.05.009
DO - 10.1016/j.ajpath.2017.05.009
M3 - Article
C2 - 28683257
AN - SCOPUS:85027543573
SN - 0002-9440
VL - 187
SP - 1984
EP - 1997
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 9
ER -